<h3>這個假期在 TipRanks 上享受 70% 的折扣</h3>
<ul>
<li>解鎖對沖基金級別的數據和強大的投資工具，以做出更聰明、更精準的決策</li>
<li>通過最新的新聞和分析保持市場領先，最大化您的投資組合潛力</li>
</ul>
<p>MedPlus Health Services Ltd.（（IN:MEDPLUS））已發佈公告。</p>
<p>MedPlus Health Services Ltd. 已披露其子公司 Optival Health Solutions Private Limited 收到了針對位於卡納塔克邦 Jayanagar 9 街區、T R Nagar 和 Shiggon Haveri 三家門店的藥品許可證的三項暫停令。這些暫停令由班加羅爾第三圈和哈維裏圈的藥品監管局助理主任根據《1940 年藥品和化妝品法》第 65 條及相關規則發佈，每項暫停適用於三天，並與涉嫌違反這些規定有關。公司估計，臨時停業可能導致約 32.4 萬印度盧比的潛在收入損失，表明對整體運營的財務影響有限，但突顯了對其零售藥房網絡合規性的持續監管審查。</p>
<p><strong>關於 MedPlus Health Services Ltd. 的更多信息</strong></p>
<p>MedPlus Health Services Ltd. 在印度零售藥房和醫療服務行業運營，主要通過其 MedPlus 藥房連鎖和子公司 Optival Health Solutions Private Limited。該公司專注於在多個州提供處方藥、非處方藥和相關醫療產品，定位為城市和半城市市場的主要有組織藥房參與者。</p>
<p><strong>平均交易量：</strong> 21,726</p>
<p><strong>技術情緒信號：</strong> 買入</p>
<p><strong>當前市值：</strong> 98.84B INR</p>
<p>在 TipRanks 的股票分析頁面查看更多關於 MEDPLUS 股票的見解。</p>

<p>MedPlus Health Services Ltd. 宣佈其子公司 Optival Health Solutions Private Limited 因涉嫌違反 1940 年《藥品和化妝品法》，在卡納塔克邦的三家門店收到了為期三天的藥品許可證暫停。預計這些暫停將導致約 3.24 萬印度盧比的潛在收入損失。公司強調了有限的財務影響，但指出監管審查仍在持續</p>

<h3>Claim 70% Off TipRanks This Holiday Season</h3>
<div class="lb-trans"><h3>這個假期在 TipRanks 上享受 70% 的折扣</h3>
</div><ul>
<li>Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions</li>
<li>Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential</li>
</ul>
<div class="lb-trans"><ul>
<li>解鎖對沖基金級別的數據和強大的投資工具，以做出更聰明、更精準的決策</li>
<li>通過最新的新聞和分析保持市場領先，最大化您的投資組合潛力</li>
</ul>
</div><p>MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) has shared an announcement.</p>
<div class="lb-trans"><p>MedPlus Health Services Ltd.（（IN:MEDPLUS））已發佈公告。</p>
</div><p>MedPlus Health Services Ltd. has disclosed that its subsidiary Optival Health Solutions Private Limited has received three suspension orders for drug licenses covering three stores in Karnataka, located at Jayanagar 9th Block, T R Nagar, and Shiggon Haveri. The suspensions, issued by Assistant Directors of the Drugs Control Administration in Bangalore Circle-3 and Haveri Circle under Rule 65 of the Drugs and Cosmetics Act, 1940 and corresponding Rules, each apply for a three-day period and are linked to alleged violations of those provisions. The company estimates a combined potential revenue loss of roughly Rs 3.24 lakh from the temporary shutdowns, indicating a limited financial impact relative to overall operations, but highlighting ongoing regulatory scrutiny over compliance in its retail pharmacy network.</p>
<div class="lb-trans"><p>MedPlus Health Services Ltd. 已披露其子公司 Optival Health Solutions Private Limited 收到了針對位於卡納塔克邦 Jayanagar 9 街區、T R Nagar 和 Shiggon Haveri 三家門店的藥品許可證的三項暫停令。這些暫停令由班加羅爾第三圈和哈維裏圈的藥品監管局助理主任根據《1940 年藥品和化妝品法》第 65 條及相關規則發佈，每項暫停適用於三天，並與涉嫌違反這些規定有關。公司估計，臨時停業可能導致約 32.4 萬印度盧比的潛在收入損失，表明對整體運營的財務影響有限，但突顯了對其零售藥房網絡合規性的持續監管審查。</p>
</div><p><strong>More about MedPlus Health Services Ltd.</strong></p>
<div class="lb-trans"><p><strong>關於 MedPlus Health Services Ltd. 的更多信息</strong></p>
</div><p>MedPlus Health Services Ltd. operates in the Indian retail pharmacy and healthcare services industry, primarily through its chain of MedPlus pharmacies and subsidiary Optival Health Solutions Private Limited. The company focuses on providing prescription drugs, over-the-counter medicines and related healthcare products across multiple states, positioning itself as a major organized pharmacy player in urban and semi-urban markets.</p>
<div class="lb-trans"><p>MedPlus Health Services Ltd. 在印度零售藥房和醫療服務行業運營，主要通過其 MedPlus 藥房連鎖和子公司 Optival Health Solutions Private Limited。該公司專注於在多個州提供處方藥、非處方藥和相關醫療產品，定位為城市和半城市市場的主要有組織藥房參與者。</p>
</div><p><strong>Average Trading Volume:</strong> 21,726</p>
<div class="lb-trans"><p><strong>平均交易量：</strong> 21,726</p>
</div><p><strong>Technical Sentiment Signal:</strong> Buy</p>
<div class="lb-trans"><p><strong>技術情緒信號：</strong> 買入</p>
</div><p><strong>Current Market Cap:</strong> 98.84B INR</p>
<div class="lb-trans"><p><strong>當前市值：</strong> 98.84B INR</p>
</div><p>See more insights into MEDPLUS stock on TipRanks’ Stock Analysis page.</p>
<div class="lb-trans"><p>在 TipRanks 的股票分析頁面查看更多關於 MEDPLUS 股票的見解。</p>
</div>

MedPlus 的子公司在卡納塔克邦的三家門店面臨為期三天的藥品許可證暫停